Frequently Asked Questions Is semaglutide safe for someone with celiac disease
A gentle, affordable dose to help hold your results once you've hit your goal
Tirzepatide, a dual GIP and GLP-1 receptor agonist marketed as Mounjaro and Zepbound, demonstrates substantial weight reduction in clinical trials, yet most patients experience periods where weight loss slows or temporarily stalls
This medication works as a stimulant and targets the chemicals in your brain instead of the hormones in your gut
Nigel Greig, a neuroscientist who focuses on drug development, is studying drugs that mimic GLP-1 as a possible treatment for Parkinsons disease
Dosing and Monitoring Requirements for Elderly Patients Appropriate dosing and vigilant monitoring are fundamental to maximising the benefits of GLP-1 therapy whilst minimising risks in older adults